Pharmacology
 |
|
11 february 2020 01:00:07 |
| Cost-effectiveness of CYP2C19-guided antiplatelet therapy in patients with acute coronary syndrome and percutaneous coronary intervention informed by real-world data (Pharmacogenomics Journal) |
|
Tweet |
| 200 viewsCategory: Genomics, Pharmacology |
 Identification of gene modules associated with survival of diffuse large B-cell lymphoma treated with CHOP-based chemotherapy (Pharmacogenomics Journal)Combining clinical and candidate gene data into a risk score for azathioprine-associated leukopenia in routine clinical practice (Pharmacogenomics Journal) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
